×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Arcus Biosciences Inc. (RCUS) NEW YORK STOCK EXCHANGE INC.

$14.59 (0.25) (-1.69%)

Market Cap: $1.33B

As of 04/19/24 04:00 PM EDT. Market closed.

(RCUS)

Arcus Biosciences Inc. (RCUS)
NEW YORK STOCK EXCHANGE INC.

$14.59
(0.25) (-1.69%)

Market Cap: $1.33B

As of 04/19/24 04:00 PM EDT. Market closed.

Add to Portfolio

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world’s largest biotechnology research hub. unlike many ... read more

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world’s largest biotechnology research hub. unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. for this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive. arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. these new drugs will then be read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$295,000
CEO Compensation (Total)
$1.12M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
511
CEO Compensation (Base)
$295,000
CEO Compensation (Total)
$1.12M
Address
.
PRICE CHART FOR ARCUS BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.97
Previous Close
$14.84
Days Range
$14.10 - $15.19
52 week range
$12.95 - $25.47
Volume
597,302
Avg. Volume (30 days)
606,048
Market Cap
$1.33B
Dividend Yield
-
P/E
(4.32)
Shares Outstanding
90,864,829
Open
$14.97
Previous Close
$14.84
Days Range
$14.10 - $15.19
52 week range
$12.95 - $25.47
Volume
597,302
Avg. Volume (30 days)
606,048
Market Cap
$1.33B
Dividend Yield
-
P/E
(4.32)
Shares Outstanding
90,864,829
FINANCIAL STATEMENTS FOR ARCUS BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARCUS BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Jarrett JenniferChief Operating OfficerMar 27, 2024 Sale$17.5511,551202,720215,253Mar 29, 2024, 04:20 PM
Jarrett JenniferChief Operating OfficerMar 18, 2024 Sale$17.9213,449240,941228,100Mar 20, 2024, 04:19 PM
Jarrett JenniferChief Operating OfficerFeb 27, 2024 Sale$20.1134,070685,148240,253Feb 28, 2024, 07:55 PM
Jarrett JenniferChief Operating OfficerFeb 26, 2024 Sale$20.0724,555492,819274,323Feb 28, 2024, 07:55 PM
Jaen Juan C.PresidentFeb 27, 2024 Sale$20.1023,132464,9531,188,233Feb 28, 2024, 07:55 PM
Jaen Juan C.PresidentFeb 26, 2024 Sale$20.063,90078,2341,211,365Feb 28, 2024, 07:55 PM
GILEAD SCIENCES, INC.10% OwnerJan 29, 2024 Buy$21.0015,238,095319,999,99530,061,124Jan 31, 2024, 05:00 PM
Goeltz II Robert C.Chief Financial OfficerJan 02, 2024 Sale$20.002,00440,08051,831Jan 04, 2024, 05:23 PM
Jaen Juan C.PresidentJan 02, 2024 Sale$20.096,975140,1281,215,265Jan 04, 2024, 05:22 PM
Jarrett JenniferChief Operating OfficerDec 22, 2023 Sale$17.7621,521382,213258,878Dec 26, 2023, 04:04 PM
Azoy AlexanderChief Accounting OfficerDec 20, 2023 Option Exercise$18.21681,23810,220Dec 22, 2023, 04:06 PM
Tang Carolyn C.General CounselDec 19, 2023 Option Exercise$18.094,07673,73587,879Dec 20, 2023, 04:10 PM
Tang Carolyn C.General CounselDec 18, 2023 Option Exercise$17.743,99170,80091,955Dec 20, 2023, 04:10 PM
Nuyten Dimitry SAChief Medical OfficerDec 19, 2023 Option Exercise$18.091,54027,85971,195Dec 20, 2023, 04:10 PM
Nuyten Dimitry SAChief Medical OfficerDec 18, 2023 Option Exercise$17.741,50726,73472,735Dec 20, 2023, 04:10 PM
Azoy AlexanderChief Accounting OfficerDec 19, 2023 Option Exercise$18.0966111,95710,288Dec 20, 2023, 04:10 PM
Azoy AlexanderChief Accounting OfficerDec 18, 2023 Option Exercise$17.7464711,47810,949Dec 20, 2023, 04:10 PM
Goeltz II Robert C.Chief Financial OfficerDec 19, 2023 Option Exercise$18.092,80850,79753,835Dec 20, 2023, 04:10 PM
Goeltz II Robert C.Chief Financial OfficerDec 18, 2023 Option Exercise$17.742,74948,76756,643Dec 20, 2023, 04:10 PM
Jarrett JenniferChief Operating OfficerDec 19, 2023 Option Exercise$18.0911,492207,890280,399Dec 20, 2023, 04:09 PM
Jarrett JenniferChief Operating OfficerDec 18, 2023 Option Exercise$17.7411,250199,575291,891Dec 20, 2023, 04:09 PM
Jaen Juan C.PresidentDec 19, 2023 Option Exercise$18.096,259113,225301,475Dec 20, 2023, 04:09 PM
Jaen Juan C.PresidentDec 18, 2023 Option Exercise$17.746,128108,711307,734Dec 20, 2023, 04:09 PM
ROSEN TERRY JChief Executive OfficerDec 19, 2023 Option Exercise$18.0914,000253,2603,866,526Dec 20, 2023, 04:09 PM
ROSEN TERRY JChief Executive OfficerDec 18, 2023 Option Exercise$17.7413,705243,1273,880,526Dec 20, 2023, 04:09 PM
Azoy AlexanderChief Accounting OfficerDec 01, 2023 Sale$14.952824,21611,596Dec 05, 2023, 04:28 PM
Jarrett JenniferChief Operating OfficerSep 22, 2023 Sale$19.9921,369427,166302,691Sep 26, 2023, 04:35 PM
Nuyten Dimitry SAChief Medical OfficerSep 18, 2023 Option Exercise$20.403,70875,64373,591Sep 20, 2023, 04:47 PM
Jarrett JenniferChief Operating OfficerSep 18, 2023 Option Exercise$20.4012,506255,122324,060Sep 20, 2023, 04:46 PM
Jarrett JenniferChief Operating OfficerJul 28, 2023 Sale$20.2545,000911,250336,566Jul 31, 2023, 04:15 PM
Azoy AlexanderChief Accounting OfficerJul 03, 2023 Sale$20.411,01820,77711,596Jul 05, 2023, 04:05 PM
GILEAD SCIENCES, INC.10% OwnerJun 28, 2023 Buy$19.261,010,00019,452,60014,823,029Jun 30, 2023, 03:12 PM
Jarrett JenniferChief Operating OfficerJun 22, 2023 Sale$19.1212,437237,795381,566Jun 26, 2023, 04:36 PM
Tang Carolyn C.General CounselJun 16, 2023 Option Exercise$19.352,89255,96095,902Jun 16, 2023, 08:17 PM
Jarrett JenniferChief Operating OfficerJun 16, 2023 Sale$19.3512,563243,094394,003Jun 16, 2023, 08:16 PM
Jaen Juan C.PresidentJun 16, 2023 Option Exercise$19.354,82093,267313,862Jun 16, 2023, 08:14 PM
ROSEN TERRY JChief Executive OfficerJun 16, 2023 Option Exercise$19.358,762169,5453,894,231Jun 16, 2023, 08:12 PM
Goeltz II Robert C.Chief Financial OfficerJun 07, 2023 Sale$20.044,04981,14259,392Jun 09, 2023, 04:05 PM
Jarrett JenniferChief Operating OfficerMar 16, 2023 Sale$16.818,729146,734406,217Mar 20, 2023, 04:12 PM
Jarrett JenniferChief Operating OfficerJan 27, 2023 Sale$23.521,60037,632414,946Jan 30, 2023, 05:04 PM
Jarrett JenniferChief Operating OfficerJan 26, 2023 Sale$23.563007,068416,546Jan 30, 2023, 05:04 PM
Goeltz II Robert C.Chief Financial OfficerDec 16, 2022 Sale$30.752,45375,43011,953Dec 16, 2022, 09:44 PM
Tang Carolyn C.General CounselDec 16, 2022 Sale$30.752,52377,58228,982Dec 16, 2022, 09:42 PM
Jarrett JenniferChief Operating OfficerDec 16, 2022 Sale$30.7516,482506,822150,212Dec 16, 2022, 09:41 PM
Jaen Juan C.PresidentDec 16, 2022 Sale$30.754,436136,407218,959Dec 16, 2022, 09:40 PM
ROSEN TERRY JChief Executive OfficerDec 16, 2022 Sale$30.7513,043401,073244,233Dec 16, 2022, 09:39 PM
Jarrett JenniferChief Operating OfficerSep 16, 2022 Sale$26.2812,677333,152130,942Sep 20, 2022, 04:08 PM
Tang Carolyn C.General CounselJun 17, 2022 Sale$22.121,52233,66524,982Jun 21, 2022, 04:23 PM
Tang Carolyn C.General CounselJun 16, 2022 Sale$20.721,40029,00825,431Jun 21, 2022, 04:23 PM
ROSEN TERRY JChief Executive OfficerJun 17, 2022 Sale$22.124,613102,034230,968Jun 21, 2022, 04:21 PM
ROSEN TERRY JChief Executive OfficerJun 16, 2022 Sale$20.724,24187,874232,329Jun 21, 2022, 04:21 PM
Jarrett JenniferChief Operating OfficerJun 17, 2022 Sale$22.126,614146,294123,282Jun 21, 2022, 04:19 PM
Jarrett JenniferChief Operating OfficerJun 16, 2022 Sale$20.726,081125,998125,233Jun 21, 2022, 04:19 PM
Jaen Juan C.PresidentJun 17, 2022 Sale$22.122,53756,116211,826Jun 21, 2022, 04:18 PM
Jaen Juan C.PresidentJun 16, 2022 Sale$20.722,33348,340212,574Jun 21, 2022, 04:18 PM
Jarrett JenniferChief Operating OfficerMar 16, 2022 Sale$31.629,617304,090105,978Mar 18, 2022, 04:43 PM
Jarrett JenniferChief Operating OfficerDec 20, 2021 Sale$41.4834,8221,444,369114,318Dec 22, 2021, 05:03 PM
Tang Carolyn C.General CounselDec 17, 2021 Sale$40.3662225,10218,048Dec 20, 2021, 04:26 PM
Tang Carolyn C.General CounselDec 16, 2021 Sale$39.8248719,39418,317Dec 20, 2021, 04:26 PM
Goeltz II Robert C.Chief Financial OfficerDec 17, 2021 Sale$40.3662125,0617,502Dec 20, 2021, 04:22 PM
Goeltz II Robert C.Chief Financial OfficerDec 16, 2021 Sale$39.8348519,3157,771Dec 20, 2021, 04:22 PM
Jaen Juan C.PresidentDec 17, 2021 Sale$40.361,10844,715202,019Dec 20, 2021, 04:19 PM
Jaen Juan C.PresidentDec 16, 2021 Sale$39.8286534,448202,498Dec 20, 2021, 04:19 PM
Jarrett JenniferChief Operating OfficerDec 17, 2021 Sale$40.367,118287,261130,955Dec 20, 2021, 04:17 PM
Jarrett JenniferChief Operating OfficerDec 16, 2021 Sale$39.825,560221,423134,031Dec 20, 2021, 04:17 PM
ROSEN TERRY JChief Executive OfficerDec 17, 2021 Sale$40.362,943118,771213,860Dec 20, 2021, 04:16 PM
ROSEN TERRY JChief Executive OfficerDec 16, 2021 Sale$39.822,29991,556215,132Dec 20, 2021, 04:16 PM
Jarrett JenniferChief Operating OfficerSep 20, 2021 Sale$35.1830,6341,077,826152,209Sep 22, 2021, 04:32 PM
Jarrett JenniferChief Operating OfficerSep 21, 2021 Sale$35.6416,866601,088117,728Sep 22, 2021, 04:32 PM
Jarrett JenniferChief Operating OfficerJun 17, 2021 Sale$23.684,863115,156135,343Jun 21, 2021, 04:51 PM
Jarrett JenniferChief Operating OfficerJun 16, 2021 Sale$24.163,96895,850140,365Jun 21, 2021, 04:51 PM
Jaen Juan C.PresidentJun 17, 2021 Sale$23.682,67563,344198,286Jun 21, 2021, 04:50 PM
Jaen Juan C.PresidentJun 16, 2021 Sale$24.162,18252,707201,048Jun 21, 2021, 04:50 PM
Jarrett JenniferChief Operating OfficerJun 04, 2021 Sale$24.911,04426,006119,174Jun 07, 2021, 04:47 PM
FALBERG KATHRYN EDirectorMar 31, 2021 Buy$28.3520,000566,996102,106Apr 02, 2021, 11:38 AM
Grossman WilliamChief Medical OfficerMar 16, 2021 Sale$35.032,12774,50910,850Mar 18, 2021, 04:37 PM
Jarrett JenniferChief Operating OfficerMar 16, 2021 Sale$35.038,661303,394116,973Mar 18, 2021, 04:36 PM
GILEAD SCIENCES INC10% OwnerJan 31, 2021 Buy$39.005,650,000220,350,00013,913,029Feb 02, 2021, 04:52 PM
Grossman WilliamChief Medical OfficerDec 16, 2020 Sale$31.352,11766,3686,727Dec 18, 2020, 04:51 PM
Goeltz II Robert C.Chief Financial OfficerSep 09, 2020 Buy$21.575,000107,8495,000Sep 09, 2020, 04:53 PM
ROSEN TERRY JChief Executive OfficerAug 07, 2020 Buy$21.4411,655249,9113,199,129Aug 11, 2020, 05:13 PM
ROSEN TERRY JChief Executive OfficerAug 10, 2020 Buy$23.3832,050749,4033,231,179Aug 11, 2020, 05:13 PM
Grossman WilliamChief Medical OfficerJul 31, 2020 Buy$19.722003,945600Aug 04, 2020, 06:13 PM
KANEKO YASUNORIDirectorJun 05, 2020 Option Exercise$7.9935,000279,65038,000Jun 08, 2020, 04:31 PM
Grossman WilliamChief Medical OfficerOct 14, 2019 Buy$8.003002,400400Oct 15, 2019, 06:15 PM
Grossman WilliamChief Medical OfficerOct 10, 2019 Buy$8.00100800100Oct 15, 2019, 06:15 PM
Jaen Juan C.PresidentJun 27, 2019 Buy$7.4410,10675,2172,774,346Jun 28, 2019, 07:07 PM
Jaen Juan C.PresidentJun 28, 2019 Buy$7.894,89438,6372,779,240Jun 28, 2019, 07:07 PM
FALBERG KATHRYN EDirectorJun 13, 2019 Buy$8.5212,935110,15282,106Jun 14, 2019, 02:24 PM
FALBERG KATHRYN EDirectorJun 12, 2019 Buy$8.4910,00084,92869,171Jun 13, 2019, 08:01 PM
FALBERG KATHRYN EDirectorJun 11, 2019 Buy$7.9010,00079,00059,171Jun 13, 2019, 08:01 PM
FALBERG KATHRYN EDirectorJun 10, 2019 Buy$8.2510,00082,50049,171Jun 11, 2019, 08:19 PM
FALBERG KATHRYN EDirectorJun 07, 2019 Buy$7.9922,065176,29739,171Jun 11, 2019, 08:19 PM
ROSEN TERRY JChief Executive OfficerJun 06, 2019 Buy$7.952,38018,9283,023,139Jun 07, 2019, 02:03 PM
ROSEN TERRY JChief Executive OfficerJun 05, 2019 Buy$7.9319,358153,4163,020,759Jun 07, 2019, 02:03 PM
ROSEN TERRY JChief Executive OfficerJun 04, 2019 Buy$7.7525,770199,8263,001,401Jun 05, 2019, 10:35 AM
ROSEN TERRY JChief Executive OfficerJun 03, 2019 Buy$8.1615,770128,7492,975,631Jun 05, 2019, 10:35 AM
Jaen Juan C.PresidentJun 03, 2019 Buy$8.2510,00082,4852,764,240Jun 04, 2019, 03:44 PM
Jaen Juan C.PresidentNov 13, 2018 Buy$11.8010,000118,0392,754,240Nov 15, 2018, 01:21 PM
ROSEN TERRY JChief Executive OfficerAug 27, 2018 Buy$14.537,957115,5863,949,211Aug 29, 2018, 01:25 PM
ROSEN TERRY JChief Executive OfficerAug 28, 2018 Buy$15.4810,650164,8453,959,861Aug 29, 2018, 01:25 PM
ROSEN TERRY JChief Executive OfficerAug 24, 2018 Buy$13.404,95466,3633,941,254Aug 24, 2018, 05:55 PM
ROSEN TERRY JChief Executive OfficerAug 23, 2018 Buy$13.502,13328,8003,936,300Aug 24, 2018, 05:55 PM
ROSEN TERRY JChief Executive OfficerAug 22, 2018 Buy$13.522,20229,7773,934,167Aug 24, 2018, 05:55 PM
ROSEN TERRY JChief Executive OfficerAug 17, 2018 Buy$13.274,80063,7133,927,874Aug 21, 2018, 07:27 PM
ROSEN TERRY JChief Executive OfficerAug 21, 2018 Buy$13.202,79036,8283,931,965Aug 21, 2018, 07:27 PM
ROSEN TERRY JChief Executive OfficerAug 20, 2018 Buy$13.211,30117,1863,929,175Aug 21, 2018, 07:27 PM
ROSEN TERRY JChief Executive OfficerAug 16, 2018 Buy$12.958,932115,6493,923,074Aug 16, 2018, 05:30 PM
ROSEN TERRY JChief Executive OfficerAug 15, 2018 Buy$12.5713,300167,2403,914,142Aug 16, 2018, 05:30 PM
ROSEN TERRY JChief Executive OfficerAug 14, 2018 Buy$12.366,16976,2393,900,842Aug 16, 2018, 05:30 PM
Jaen Juan C.PresidentAug 13, 2018 Buy$11.773,15937,1682,744,240Aug 13, 2018, 05:41 PM
Jaen Juan C.PresidentAug 10, 2018 Buy$11.942,57930,7962,741,081Aug 13, 2018, 05:41 PM
Jaen Juan C.PresidentAug 09, 2018 Buy$11.934,26250,8552,738,502Aug 13, 2018, 05:41 PM
ROSEN TERRY JChief Executive OfficerAug 13, 2018 Buy$11.753,27938,5343,894,673Aug 13, 2018, 05:38 PM
ROSEN TERRY JChief Executive OfficerAug 10, 2018 Buy$11.942,55030,4513,891,394Aug 13, 2018, 05:38 PM
ROSEN TERRY JChief Executive OfficerAug 09, 2018 Buy$11.924,10048,8693,888,844Aug 13, 2018, 05:38 PM
Jaen Juan C.PresidentMar 19, 2018 Buy$15.0066,666999,9902,734,240Mar 19, 2018, 05:27 PM
ROSEN TERRY JChief Executive OfficerMar 19, 2018 Buy$15.0066,666999,9903,884,744Mar 19, 2018, 05:23 PM
FALBERG KATHRYN EDirectorMar 19, 2018 Buy$15.0030,000450,00080,504Mar 19, 2018, 05:23 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Jarrett JenniferChief Operating Officer03/27/2024202,720
Jarrett JenniferChief Operating Officer03/18/2024240,941
Jarrett JenniferChief Operating Officer02/27/2024685,148
Jarrett JenniferChief Operating Officer02/26/2024492,819
Jaen Juan C.President02/27/2024464,953
Jaen Juan C.President02/26/202478,234
GILEAD SCIENCES, INC.10% Owner01/29/2024319,999,995
Goeltz II Robert C.Chief Financial Officer01/02/202440,080
Jaen Juan C.President01/02/2024140,128
Jarrett JenniferChief Operating Officer12/22/2023382,213
Azoy AlexanderChief Accounting Officer12/20/20231,238
Tang Carolyn C.General Counsel12/19/202373,735
Tang Carolyn C.General Counsel12/18/202370,800
Nuyten Dimitry SAChief Medical Officer12/19/202327,859
Nuyten Dimitry SAChief Medical Officer12/18/202326,734
Azoy AlexanderChief Accounting Officer12/19/202311,957
Azoy AlexanderChief Accounting Officer12/18/202311,478
Goeltz II Robert C.Chief Financial Officer12/19/202350,797
Goeltz II Robert C.Chief Financial Officer12/18/202348,767
Jarrett JenniferChief Operating Officer12/19/2023207,890
Jarrett JenniferChief Operating Officer12/18/2023199,575
Jaen Juan C.President12/19/2023113,225
Jaen Juan C.President12/18/2023108,711
ROSEN TERRY JChief Executive Officer12/19/2023253,260
ROSEN TERRY JChief Executive Officer12/18/2023243,127
Azoy AlexanderChief Accounting Officer12/01/20234,216
Jarrett JenniferChief Operating Officer09/22/2023427,166
Nuyten Dimitry SAChief Medical Officer09/18/202375,643
Jarrett JenniferChief Operating Officer09/18/2023255,122
Jarrett JenniferChief Operating Officer07/28/2023911,250
Azoy AlexanderChief Accounting Officer07/03/202320,777
GILEAD SCIENCES, INC.10% Owner06/28/202319,452,600
Jarrett JenniferChief Operating Officer06/22/2023237,795
Tang Carolyn C.General Counsel06/16/202355,960
Jarrett JenniferChief Operating Officer06/16/2023243,094
Jaen Juan C.President06/16/202393,267
ROSEN TERRY JChief Executive Officer06/16/2023169,545
Goeltz II Robert C.Chief Financial Officer06/07/202381,142
Jarrett JenniferChief Operating Officer03/16/2023146,734
Jarrett JenniferChief Operating Officer01/27/202337,632
Jarrett JenniferChief Operating Officer01/26/20237,068
Goeltz II Robert C.Chief Financial Officer12/16/202275,430
Tang Carolyn C.General Counsel12/16/202277,582
Jarrett JenniferChief Operating Officer12/16/2022506,822
Jaen Juan C.President12/16/2022136,407
ROSEN TERRY JChief Executive Officer12/16/2022401,073
Jarrett JenniferChief Operating Officer09/16/2022333,152
Tang Carolyn C.General Counsel06/17/202233,665
Tang Carolyn C.General Counsel06/16/202229,008
ROSEN TERRY JChief Executive Officer06/17/2022102,034
ROSEN TERRY JChief Executive Officer06/16/202287,874
Jarrett JenniferChief Operating Officer06/17/2022146,294
Jarrett JenniferChief Operating Officer06/16/2022125,998
Jaen Juan C.President06/17/202256,116
Jaen Juan C.President06/16/202248,340
Jarrett JenniferChief Operating Officer03/16/2022304,090
Jarrett JenniferChief Operating Officer12/20/20211,444,369
Tang Carolyn C.General Counsel12/17/202125,102
Tang Carolyn C.General Counsel12/16/202119,394
Goeltz II Robert C.Chief Financial Officer12/17/202125,061
Goeltz II Robert C.Chief Financial Officer12/16/202119,315
Jaen Juan C.President12/17/202144,715
Jaen Juan C.President12/16/202134,448
Jarrett JenniferChief Operating Officer12/17/2021287,261
Jarrett JenniferChief Operating Officer12/16/2021221,423
ROSEN TERRY JChief Executive Officer12/17/2021118,771
ROSEN TERRY JChief Executive Officer12/16/202191,556
Jarrett JenniferChief Operating Officer09/20/20211,077,826
Jarrett JenniferChief Operating Officer09/21/2021601,088
Jarrett JenniferChief Operating Officer06/17/2021115,156
Jarrett JenniferChief Operating Officer06/16/202195,850
Jaen Juan C.President06/17/202163,344
Jaen Juan C.President06/16/202152,707
Jarrett JenniferChief Operating Officer06/04/202126,006
FALBERG KATHRYN EDirector03/31/2021566,996
Grossman WilliamChief Medical Officer03/16/202174,509
Jarrett JenniferChief Operating Officer03/16/2021303,394
GILEAD SCIENCES INC10% Owner01/31/2021220,350,000
Grossman WilliamChief Medical Officer12/16/202066,368
Goeltz II Robert C.Chief Financial Officer09/09/2020107,849
ROSEN TERRY JChief Executive Officer08/07/2020249,911
ROSEN TERRY JChief Executive Officer08/10/2020749,403
Grossman WilliamChief Medical Officer07/31/20203,945
KANEKO YASUNORIDirector06/05/2020279,650
Grossman WilliamChief Medical Officer10/14/20192,400
Grossman WilliamChief Medical Officer10/10/2019800
Jaen Juan C.President06/27/201975,217
Jaen Juan C.President06/28/201938,637
FALBERG KATHRYN EDirector06/13/2019110,152
FALBERG KATHRYN EDirector06/12/201984,928
FALBERG KATHRYN EDirector06/11/201979,000
FALBERG KATHRYN EDirector06/10/201982,500
FALBERG KATHRYN EDirector06/07/2019176,297
ROSEN TERRY JChief Executive Officer06/06/201918,928
ROSEN TERRY JChief Executive Officer06/05/2019153,416
ROSEN TERRY JChief Executive Officer06/04/2019199,826
ROSEN TERRY JChief Executive Officer06/03/2019128,749
Jaen Juan C.President06/03/201982,485
Jaen Juan C.President11/13/2018118,039
ROSEN TERRY JChief Executive Officer08/27/2018115,586
ROSEN TERRY JChief Executive Officer08/28/2018164,845
ROSEN TERRY JChief Executive Officer08/24/201866,363
ROSEN TERRY JChief Executive Officer08/23/201828,800
ROSEN TERRY JChief Executive Officer08/22/201829,777
ROSEN TERRY JChief Executive Officer08/17/201863,713
ROSEN TERRY JChief Executive Officer08/21/201836,828
ROSEN TERRY JChief Executive Officer08/20/201817,186
ROSEN TERRY JChief Executive Officer08/16/2018115,649
ROSEN TERRY JChief Executive Officer08/15/2018167,240
ROSEN TERRY JChief Executive Officer08/14/201876,239
Jaen Juan C.President08/13/201837,168
Jaen Juan C.President08/10/201830,796
Jaen Juan C.President08/09/201850,855
ROSEN TERRY JChief Executive Officer08/13/201838,534
ROSEN TERRY JChief Executive Officer08/10/201830,451
ROSEN TERRY JChief Executive Officer08/09/201848,869
Jaen Juan C.President03/19/2018999,990
ROSEN TERRY JChief Executive Officer03/19/2018999,990
FALBERG KATHRYN EDirector03/19/2018450,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ARCUS BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.10,035,1700.00489%4.33%Other
GEODE CAPITAL MANAGEMENT, LLC1,142,1690.00228%5.99%Other
SUVRETTA CAPITAL MANAGEMENT, LLC957,3040.83%60.33%Growth At A Reasonable Price
BALYASNY ASSET MANAGEMENT L.P.515,4530.02%10.98%Event Driven
PLATINUM INVESTMENT MANAGEMENT LTD204,3980.16%No changeGrowth At A Reasonable Price, Value
RENAISSANCE TECHNOLOGIES LLC123,5000.00365%-13.52%Other
ORBIMED ADVISORS LLC117,0000.04%NewOther
UBS OCONNOR LLC53,2460.07%-46.44%Value
ALPS ADVISORS INC52,4710.00788%-4.51%Other
UBS OCONNOR LLC35,000 (Call)0.00164%No changeValue
AQR CAPITAL MANAGEMENT LLC10,9470.00039%NewOther
CHANGE IN SHARES OUTSTANDING FOR ARCUS BIOSCIENCES INC
STOCK BUYBACKS FOR ARCUS BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.80%
1Q
12/31/2023
06/30/2023
2.73%
2Q
12/31/2023
03/31/2023
3.01%
3Q
12/31/2023
12/31/2022
3.38%
4Q
12/31/2023
09/30/2022
4.16%
5Q
12/31/2023
06/30/2022
4.74%
6Q
12/31/2023
03/31/2022
5.62%
7Q
12/31/2023
12/31/2021
1.62%
8Q
12/31/2023
09/30/2021
7.26%
9Q
12/31/2023
06/30/2021
7.82%
10Q
12/31/2023
03/31/2021
12.10%
11Q
12/31/2023
12/31/2020
18.16%
12Q
12/31/2023
09/30/2020
15.43%
13Q
12/31/2023
06/30/2020
54.87%
14Q
12/31/2023
03/31/2020
69.82%
15Q
12/31/2023
12/31/2019
70.70%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.80%
1Q
06/30/2023
2.73%
2Q
03/31/2023
3.01%
3Q
12/31/2022
3.38%
4Q
09/30/2022
4.16%
5Q
06/30/2022
4.74%
6Q
03/31/2022
5.62%
7Q
12/31/2021
1.62%
8Q
09/30/2021
7.26%
9Q
06/30/2021
7.82%
10Q
03/31/2021
12.10%
11Q
12/31/2020
18.16%
12Q
09/30/2020
15.43%
13Q
06/30/2020
54.87%
14Q
03/31/2020
69.82%
15Q
12/31/2019
70.70%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ARCUS BIOSCIENCES INC
LOADING...